The Cardiovascular Market Outlook To 2008

REUTERS BUSINESS INSIGHT,HEALTHCARE

Table of Contents
The Cardiovascular Market Outlook to 2008
Executive Summary 12
Patient potential 12
Risk factors 12
Cardiovascular diseases 12
Acute thrombotic events 13
Cardiovascular procedures 14
Global cardiovascular market analysis 15
Growth in the anti-hypertensives market is driven by sales of the ARBs, which
continue to benefit from patent protection 15
Statins continue to lead the anti-dyslipidemic market, although generic
competition is intensifying 15
The rapid uptake of Plavix boosts strong growth in antithrombotics 16
Growth in the LMWH market bolstered by physicians switching from UFH to
newer LMWH brands 16
Cardiac therapy holds enormous potential for new drugs due to high unmet
need within substantial patient populations 17
Leading players in the cardiovascular market 17
Analysis of potential future cardiovascular blockbusters 19
Crestor capitalizes on the dyslipidemia market 19
Exanta – the first oral anti-coagulant to market in 50 years 19
Norvasc/Lipitor – Pfizer’s marketing strength will create a blockbuster 20